Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Double-blind Parallel Group Study to Compare the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Subjects With Mild to Moderate Essential Hypertension

NCT01631227 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01631227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01631227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Double-blind Parallel Group Study to Compare the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Subjects With Mild to Moderate Essential Hypertension
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
April 30, 2013
Enrollment
665 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension